1,149 results on '"Efstathiou, Jason A."'
Search Results
202. IMPACT OF SYNCHRONOUS BLADDER CANCER ON RECURRENCE-FREE SURVIVAL AFTER SURGICAL TREATMENT FOR PRIMARY URETHRAL CANCER: RESULTS FROM THE INTERNATIONAL COLLABORATION ON PRIMARY URETHRAL CARCINOMA (ICPUC): MP13-03
203. Case 2-2014: A 44-Year-Old Man with a Lesion on the Penis
204. INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.
205. The impact of a positive family history on clinical and pathologic outcomes of active surveillance for prostate cancer.
206. EA8185: Phase II study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), ECOG-ACRIN/nrg collaboration.
207. INTACT (S/N1806) phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle-invasive bladder cancer: Safety update on first 73 patients.
208. Bladder-sparing approaches to invasive disease
209. Resolution of a High Grade and Metastatic BK Polyomavirus-Associated Urothelial Cell Carcinoma Following Radical Allograft Nephroureterectomy and Immune Checkpoint Treatment: A Case Report
210. Contributors
211. Bladder Cancer
212. Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer
213. PROSTATE CANCER: Proton therapy—revolutionary advance or diminishing returns?
214. UROLOGICAL CANCER: The benefits of intermittent androgen-deprivation therapy
215. Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality
216. The Program for Enhanced Training in Cancer: An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan Africa
217. Quality Indicators for Bladder Cancer Services: A Collaborative Review
218. Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer
219. Abstract D085: Differences in the use of proton beam therapy among patients diagnosed with American Society for Radiation Oncology Group 1 proton beam therapy indication cancer types in the United States
220. An analysis of trends in prostate cancer treatment from a CMS database.
221. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer
222. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
223. Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.
224. INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer—SWOG/NRG1806.
225. Radiotherapy use in the treatment of gastrointestinal cancers in Medicare patients: An analysis of a CMS database.
226. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
227. EDITORIAL COMMENT
228. 328. Kaposi Sarcoma in High Population ART Utilization Setting: An Observational Study in Botswana
229. The ‘CaP Calculator’: an online decision support tool for clinically localized prostate cancer
230. Prostatic Duct Adenocarcinoma: Clinical Characteristics, Treatment Options, and Outcomes - a Rare Cancer Network Study
231. HORMONAL THERAPIES: ADT for prostate cancer: true love or heartbreak?
232. Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
233. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis
234. Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression
235. Comorbidity, body mass index, and age and risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
236. Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model
237. Immunotherapy and Radiation – A New Combined Treatment Approach for Bladder Cancer?
238. Obesity and mortality in men with locally advanced prostate cancer: Analysis of RTOG 85-31
239. Influence of Body Mass Index on Prostate-Specific Antigen Failure After Androgen Suppression and Radiation Therapy for Localized Prostate Cancer
240. Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]
241. Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
242. Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer.
243. The current state of randomized clinical trial evidence for prostate brachytherapy
244. Proton therapy for prostate cancer: A review of the rationale, evidence, and current state
245. Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level
246. Association Between Declared Hurricane Disasters and Survival of Patients With Lung Cancer Undergoing Radiation Treatment
247. Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69–70
248. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
249. Molecular Characterization of Neuroendocrine-like Bladder Cancer
250. POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan Africa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.